EspeRare’s president & executive director are authors of the chapter on the role of Disease Advocacy Organizations in orphan drug development within the book entitled Orphan Drugs and Rare Diseases newly published by the Royal Society of Chemistry. Click here to view chapter abstract
The book is an up-to-date monograph written by a combination of academic and industry experts working in the field of orphan diseases drug development, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat.
To view book content click here
